1-91698125-C-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_003243.5(TGFBR3):āc.2293G>Cā(p.Gly765Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00398 in 1,613,652 control chromosomes in the GnomAD database, including 52 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_003243.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGFBR3 | NM_003243.5 | c.2293G>C | p.Gly765Arg | missense_variant | 15/17 | ENST00000212355.9 | NP_003234.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGFBR3 | ENST00000212355.9 | c.2293G>C | p.Gly765Arg | missense_variant | 15/17 | 1 | NM_003243.5 | ENSP00000212355 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00403 AC: 613AN: 152114Hom.: 5 Cov.: 32
GnomAD3 exomes AF: 0.00711 AC: 1787AN: 251370Hom.: 14 AF XY: 0.00643 AC XY: 873AN XY: 135860
GnomAD4 exome AF: 0.00397 AC: 5800AN: 1461420Hom.: 46 Cov.: 30 AF XY: 0.00389 AC XY: 2826AN XY: 727020
GnomAD4 genome AF: 0.00405 AC: 617AN: 152232Hom.: 6 Cov.: 32 AF XY: 0.00457 AC XY: 340AN XY: 74418
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
TGFBR3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 18, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at